Brind.
  1. CEO Alex Zhavoronkov predicts AI can revolutionize the field of drug discovery.

Insilico's AI platform developed rentosertib for IPF, and CEO Alex Zhavoronkov presented findings at Sorbonne.

1 report, 1 independent Updated Sep 8
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Insilico's AI platform developed rentosertib for IPF, and CEO Alex Zhavoronkov presented findings at Sorbonne.

Who's involved

What this event is mainly about
Insilico MedicineAlex Zhavoronkov

Keep exploring

Part of

CEO Alex Zhavoronkov predicts AI can revolutionize the field of drug discovery. All 1 developments

The entities involved

Related events

Coverage

Newest first; wire copies grouped